Sign in

CIK 0000818686 · Large accelerated filer

TEVA PHARMACEUTICAL INDUSTRIES LTD

Sign in to watch
Ticker
TEVA
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Israel
Entity type
operating
Phone
972 (3) 914-8213
Business address
TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
Former names
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
  1. 4 Open-market sale Executive VP Global Operations sold 8,000 shares at $12.51 ($100,080)
  2. 4 Open-market sale Exec. VP Chief Legal Officer sold 17,016 shares at $12.14 ($206,612)
  3. 4 Open-market sale See "Remarks" below sold 72,130.54 shares at $13.03 ($939,760)
  4. 4 Open-market sale Executive VP, Global R&D sold 11,472 shares at $12.14 ($139,295)
  5. 4 Open-market sale Executive VP Global Operations sold 8,140 shares at $12.14 ($98,785)
  6. 4 Derivatives Options or other derivatives
  7. 4 Option exercise Director acquired 2,470 shares (option exercise)
  8. SC 13G/A Stake Amended Statement of Ownership
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 8-K Event Results of operations
  15. 4 Open-market sale Exec. VP Chief Legal Officer sold 12,538 shares at $12.24 ($153,471)
  16. 4 Option exercise President and CEO acquired 26,867 shares (option exercise)
  17. 4 Option exercise See "Remarks" below acquired 15,523 shares (option exercise)
  18. 4 Open-market sale EVP, North America Commercial sold 4,799 shares at $12.27 ($58,884)
  19. 4 Open-market sale EVP, Growth Markets Commercial sold 4,155 shares at $12.24 ($50,864)
  20. 4 Open-market sale Executive VP, Global R&D sold 5,544 shares at $12.27 ($68,025)

Page 38 of 128 · 2,555 filings